Financial Architects, Inc Abbott Laboratories Transaction History

Financial Architects, Inc

$657 Million
Q2 2023

A detailed history of Financial Architects, Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Financial Architects, Inc holds 11,426 shares of ABT stock, worth $1.46 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

11,426

Previous 10,828 5.52%

Holding current value

$1.46 Million

Previous $1.1 Million 13.59%

% of portfolio

0.19%

Previous 0.18%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$100.78 - $112.29 $60,266 - $67,149	598 Added 5.52%	11,426 $1.25 Million
Q1 2023 May 12, 2023	BUY	$96.86 - $114.01 $14,238 - $16,759	147 Added 1.38%	10,828 $1.1 Million
Q4 2022 Feb 06, 2023	BUY	$95.06 - $111.52 $18,631 - $21,857	196 Added 1.87%	10,681 $1.17 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $30,866 - $35,737	319 Added 3.14%	10,485 $1.02 Million
Q2 2022 Aug 11, 2022	BUY	$102.07 - $123.37 $4,286 - $5,181	42 Added 0.41%	10,166 $1.1 Million
Q1 2022 May 05, 2022	SELL	$114.02 - $139.04 $119,492 - $145,713	-1,048 Reduced 9.38%	10,124 $1.2 Million
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $97,391 - $119,250	-843 Reduced 7.02%	11,172 $1.57 Million
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $228,886 - $253,215	1,962 Added 19.52%	12,015 $1.42 Million
Q2 2021 Aug 10, 2021	SELL	$105.79 - $124.53 $31,842 - $37,483	-301 Reduced 2.91%	10,053 $1.17 Million
Q1 2021 May 17, 2021	BUY	$108.84 - $128.23 $6,312 - $7,437	58 Added 0.56%	10,354 $1.24 Million
Q4 2020 Feb 17, 2021	BUY	$105.0 - $114.42 $5,775 - $6,293	55 Added 0.54%	10,296 $1.13 Million
Q3 2020 Nov 09, 2020	BUY	$91.64 - $111.29 $8,889 - $10,795	97 Added 0.96%	10,241 $1.12 Million
Q2 2020 Aug 11, 2020	BUY	$76.57 - $98.0 $78,867 - $100,940	1,030 Added 11.3%	10,144 $927,000
Q1 2020 May 07, 2020	SELL	$62.82 - $91.86 $8,983 - $13,135	-143 Reduced 1.54%	9,114 $719,000
Q4 2019 Feb 14, 2020	SELL	$78.51 - $87.4 $90,679 - $100,947	-1,155 Reduced 11.09%	9,257 $804,000
Q3 2019 Nov 06, 2019	SELL	$81.84 - $88.74 $1,309 - $1,419	-16 Reduced 0.15%	10,412 $871,000
Q2 2019 Aug 14, 2019	SELL	$72.88 - $85.0 $6,559 - $7,650	-90 Reduced 0.86%	10,428 $877,000
Q1 2019 May 13, 2019	BUY	$66.22 - $80.06 $696,501 - $842,071	10,518 New	10,518 $841,000
Q1 2019 May 03, 2019	SELL	$66.22 - $80.06 $701,733 - $848,395	-10,597 Closed	0 $0
Q4 2018 Feb 01, 2019	SELL	$65.56 - $74.27 $262 - $297	-4 Reduced 0.04%	10,597 $767,000
Q3 2018 Oct 29, 2018	BUY	$60.81 - $73.36 $121 - $146	2 Added 0.02%	10,601 $777,000
Q2 2018 Aug 03, 2018	SELL	$57.57 - $63.54 $4,893 - $5,400	-85 Reduced 0.8%	10,599 $647,000
Q1 2018 Apr 23, 2018	BUY	$56.27 - $63.62 $112 - $127	2 Added 0.02%	10,684 $640,000
Q4 2017 Feb 12, 2018	SELL	$53.68 - $57.47 $3,596 - $3,850	-67 Reduced 0.62%	10,682 $609,000
Q3 2017 Nov 01, 2017	BUY	$48.06 - $53.64 $506,984 - $565,848	10,549 Added 5274.5%	10,749 $574,000
Q3 2017 Oct 23, 2017	BUY	$48.06 - $53.64 $9,612 - $10,728	200	200 $11,000

Others Institutions Holding ABT

# of Institutions

3,217

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $224B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Architects, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Financial Architects, Inc with notifications on news.

Account

Financial Architects, Inc Abbott Laboratories Transaction History